IL-17a promotes hepatocellular carcinoma by increasing FAP expression in hepatic stellate cells via activation of the STAT3 signaling pathway

Dapeng Sun,Wen Li,Dongyang Ding,Kunjiang Tan,Wenbin Ding,Zongyan Wang,Siyuan Fu,Guojun Hou,Wei-ping Zhou,Fangming Gu

DOI: https://doi.org/10.1038/s41420-024-01995-4

2024-05-15

Cell Death Discovery

Abstract:Studies have shown that hepatic stellate cells (HSCs) and interleukin-17a (IL-17a) play important roles in liver tumorigenesis. In addition, fibroblast activation protein-α (FAP) has been shown to be a key regulator of hepatic stellate cell activation. In this study, in vivo and in vitro experiments were performed to verify the promoting effects of IL-17a administration, IL-17a overexpression, and FAP upregulation in HSCs on liver fibrosis and liver tumorigenesis. The cleavage under targets & release using nuclease (CUT&RUN) technique was used to verify the binding status of STAT3 to the FAP promoter. The in vitro studies showed that IL-17a activated HSCs and promoted HCC development and progression. FAP and IL-17a overexpression also activated HSCs, promoted HCC cell proliferation and migration, and inhibited HCC cell apoptosis. The in vivo studies suggested that IL-17a and FAP overexpression in HSCs facilitated liver tumor development and progression. The CUT&RUN results indicated that FAP expression was regulated by STAT3, which could bind to the FAP promoter region and regulate its transcription status. We concluded that IL-17a promoted HCC by increasing FAP expression in HSCs via activation of the STAT3 signaling pathway.

cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how interleukin - 17a (IL - 17a) promotes the development of hepatocellular carcinoma (HCC) by increasing the expression of fibroblast activation protein - α (FAP) in hepatic stellate cells (HSCs). Specifically, the research aims to verify the following points:

1. **The influence of IL - 17a on the activation of HSCs**: The research has verified the effects of IL - 17a administration, over - expression and FAP up - regulation on liver fibrosis and liver tumorigenesis through in vivo and in vitro experiments.

2. **The regulatory mechanism of FAP expression**: The CUT&RUN technique was used to verify the binding of the STAT3 transcription factor to the FAP promoter region, thereby revealing the regulatory mechanism of FAP expression.

3. **The influence of IL - 17a and FAP over - expression on HCC cells**: The research studied how IL - 17a and FAP over - expression in HSCs promote the development and progression of liver tumors.

### Main findings
- **The relationship between IL - 17a and the activation of HSCs**: IL - 17a promotes the development and progression of HCC by activating HSCs. The over - expression of FAP and IL - 17a also activates HSCs, promotes the proliferation and migration of HCC cells, and inhibits the apoptosis of HCC cells.
- **The regulation of FAP expression**: The CUT&RUN results show that FAP expression is regulated by STAT3, and STAT3 can bind to the FAP promoter region and regulate its transcriptional state.
- **The results of in vivo experiments**: HSCs with IL - 17a and FAP over - expression promote the development and progression of liver tumors.

### Research significance
This research reveals the mechanism by which IL - 17a promotes the development of HCC by activating HSCs and up - regulating FAP expression. These findings are helpful for better understanding the pathogenesis of HCC and provide a theoretical basis for the development of new treatment strategies.